English:US Search You are here: Home » Products » For the Burn and Wound Surgeon » Integra® Flowable Wound Matrix For the Burn and Wound Surgeon Integra® Dermal Regeneration Template Single Layer Integra® Dermal Regeneration Template Integra® Flowable Wound Matrix For the Extremity Reconstruction Surgeon For the Liver Surgeon For the Neurosurgeon Instruments Surgical Instruments Customer Portal Integra News Integra Events Transparence Loi Bertrand Professionnels de santé exerçant en France, veuillez consulter la page Bienvenue. Integra® Flowable Wound Matrix Solution for Use in Deep Soft Tissue or Tunneling Wounds The INTEGRA® Flowable Wound Matrix is an advanced wound care matrix comprised of a granulated cross-linked bovine tendon collagen and glycosaminoglycan. The granulated collagen-glycosaminoglycan is hydrated with saline and applied in difficult to access wound sites and tunneled wounds. It provides a scaffold for cellular invasion and capillary growth. The INTEGRA® Flowable Wound Matrix is mixed with sterile saline solution at the time of application to form a gel-like consistency. This flowable wound matrix is designed for use in deep soft tissue or tunneling wounds, such as diabetic ulcers, pressure ulcers, venous ulcers, chronic vascular ulcers and other wounds where a flowable wound matrix is appropriate. When a wound is found to “tunnel” into deep soft tissue and has an irregular geometry, grafting with a sheet form is not adequate. In order to effectively correct the defect, one must obtain contact with the wound bed and fill the wound. This can be accomplished with the INTEGRA® Flowable Wound Matrix, which is administered through a syringe with a flexible injector. This composition and method of administration allow for complete coverage in deep creviced wounds in a minimally invasive manner. Indications INTEGRA® Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including : Surgical wounds (donor sites/grafts, post-Moh’s surgery, postlaser surgery, podiatric, wound dehiscence). Diabetic ulcers. Diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use. Contraindications This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. The device is not indicated for use in third degree burns. Ordering Information Reference Description Quantity FDR 301 Flowable Wound Matrix 1 Unit/Kit 3cc Product Catalogues Reference Description Quantity FDR 301 Flowable Wound Matrix 1 Unit/Kit 3cc Regulatory Information Class III INTEGRA LifeSciences Corporation 1100 Campus Road, Princeton, New Jersey 08540 • USA Integra LifeSciences Services (France) Immeuble Sequoia 2 • 97 allée Alexandre Borodine Parc technologique de la Porte des Alpes 69800 Saint Priest • FRANCE Phone: +33 (0)4 37 47 59 00 • fax: +33 (0)4 37 47 59 30 integralife.eu Legal information Availability of these products might vary from a given country or region to another, as a result of speciﬁc local regulatory approval or clearance requirements for sale in such country or region. • Consult product labels and inserts for any indications, contraindications, hazards, warnings, precautions and instructions for use. • Non contractual document. Integra reserves the right, without prior notice, to modify the products in order to improve their quality. • Warning: Applicable laws restrict these products to sale by or on the order of a physician. Please contact Integra customer service should you need any additional information on devices classiﬁcation.Products mentioned in this document are CE class III devices. All the medical devices mentioned on this document are CE marked in accordance with the applicable European laws, unless specifically identified as “NOT CE MARKED”. Integra and the Integra logo are registered trademarks of Integra LifeSciences Corporation in the United States and/or other countries ©2017 Integra LifeSciences Corporation. All rights reserved Last modification date: 07/2021. 0829103-2-EN Document for use in Europe, Middle-East & Africa only. For more information, please contact your Integra representative. For complete product information, please consult product labels and inserts for any indications, contraindications, hazards, warnings, precautions, and instructions for use. Message for healthcare professionals working in France only / Message à destination des professionnels de santé exerçant en France: Ce site n'est pas en accord avec la loi Bertrand; les pages produits ne vous sont pas adressées. Pour tout renseignement sur la société Integra et la loi Bertrand, veuillez consulter la page bienvenue. © Copyright 2010-2018 Integra LifeSciences Corporation. All rights reserved. | Terms of use | Privacy policy | Sitemap integralife.eu cookie policy We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. Accept Cookies Cookie Settings